Malignant gliomaPRADOS, Michael D.Seminars in oncology. 2000, Vol 27, Num 3, issn 0093-7754, 47 p., SUP6Serial Issue

Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitisFRIEDMAN, H. S.Seminars in oncology. 2000, Vol 27, Num 3, pp 35-40, issn 0093-7754, SUP6Article

Future directions in the treatment of malignant gliomas with temozolomidePRADOS, M. D.Seminars in oncology. 2000, Vol 27, Num 3, pp 41-46, issn 0093-7754, SUP6Article

Temozolomide in malignant gliomasYUNG, W. K. A.Seminars in oncology. 2000, Vol 27, Num 3, pp 27-34, issn 0093-7754, SUP6Article

Biology and treatment of malignant gliomaPRADOS, M. D; LEVIN, V.Seminars in oncology. 2000, Vol 27, Num 3, pp 1-10, issn 0093-7754, SUP6Article

Clinical trial end points in malignant glioma : Need for effective trial design strategyBRADA, M; YUNG, W. K. A.Seminars in oncology. 2000, Vol 27, Num 3, pp 11-19, issn 0093-7754, SUP6Article

Issues in assessing and interpreting quality of life in patients with malignant gliomaGILBERT, M; ARMSTRONG, T; MEYERS, C et al.Seminars in oncology. 2000, Vol 27, Num 3, pp 20-26, issn 0093-7754, SUP6Article

Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone ProteinCRANE, Courtney A; HAN, Seunggu J; MCDERMOTT, Michael W et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 205-214, issn 1078-0432, 10 p.Article

Impact of bevacizumab chemotherapy on craniotomy wound healing: Clinical articleCLARK, Aaron J; BUTOWSKI, Nicholas A; AGHI, Manish K et al.Journal of neurosurgery. 2011, Vol 114, Num 6, pp 1609-1616, issn 0022-3085, 8 p.Article

p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma XenograftsDINCA, Eduard B; LU, Kan V; SARKARIA, Jann N et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 24, pp 10034-10039, issn 0008-5472, 6 p.Article

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma : A report by the cintredekin besudotox intraparenchymal study groupKUNWAR, Sandeep; PRADOS, Michael D; ALDAPE, Kenneth D et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 837-844, issn 0732-183X, 8 p.Article

Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab TreatmentCLARK, Aaron J; LAMBORN, Kathleen R; BUTOWSKI, Nicholas A et al.Neurosurgery. 2012, Vol 70, Num 2, pp 361-370, issn 0148-396X, 10 p.Article

A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAPHIOANH LEIA NGHIEMPHU; WEN, Patrick Y; CHANG, Susan M et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 5, pp 1422-1427, issn 0360-3016, 6 p.Article

Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis: Case reportGUPPY, Kern H; AKINS, Paul T; MOES, Gregory S et al.Journal of neurosurgery. Spine. 2009, Vol 10, Num 6, pp 557-563, issn 1547-5654, 7 p.Article

Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma : a North American brain tumor consortium studyPRADOS, Michael D; YUNG, W. K. A; WEN, Patrick Y et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 6, pp 1059-1067, issn 0344-5704, 9 p.Article

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults : Clinical articleCHANG, Edward F; SMITH, Justin S; CHANG, Susan M et al.Journal of neurosurgery. 2008, Vol 109, Num 5, pp 817-824, issn 0022-3085, 8 p.Article

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaPELLOSKI, Christopher E; BALLMAN, Karla V; WOO, Shiao Y et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2288-2294, issn 0732-183X, 7 p.Article

Radiation therapy for intracranial germ cell tumorsHAAS-KOGAN, Daphne A; MISSETT, Brian T; LE, Quynh-Thu et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 2, pp 511-518, issn 0360-3016, 8 p.Article

A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors: a North American brain tumor consortium reportCHANG, Susan M; KUHN, John G; ROBINS, H. Ian et al.Investigational new drugs. 2003, Vol 21, Num 4, pp 429-433, issn 0167-6997, 5 p.Article

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationJENKINS, Robert B; YUANYUAN XIAO; BRACCI, Paige et al.Nature genetics. 2012, Vol 44, Num 10, pp 1122-1125, issn 1061-4036, 4 p.Article

SSBP2 Variants Are Associated with Survival in Glioblastoma PatientsYUANYUAN XIAO; DECKER, Paul A; CHANG, Susan M et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3154-3162, issn 1078-0432, 9 p.Article

Phase 1 Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03LEE, Eudocia Q; PUDUVALLI, Vinay K; ROBINS, H. Ian et al.Clinical cancer research (Print). 2012, Vol 18, Num 21, pp 6032-6039, issn 1078-0432, 8 p.Article

Clinical Characteristics and Outcomes for a Modern Series of Primary Gliosarcoma PatientsHAN, Seunggu J; YANG, Isaac; AHN, Brian J et al.Cancer. 2010, Vol 116, Num 5, pp 1358-1366, issn 0008-543X, 9 p.Article

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaPRADOS, Michael D; CHANG, Susan M; FEDOROFF, Anne et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 579-584, issn 0732-183X, 6 p.Article

Pharmacokinetic and Tumor Distribution Characteristics of Temsirolimus in Patients with Recurrent Malignant GliomaKUHN, John G; CHANG, Susan M; DEANGELIS, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7401-7406, issn 1078-0432, 6 p.Article